BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Bavarian Nordic Takes on Pfizer-BioNTech with COVID-19 Booster Candidate

  Bavarian Nordic announced that the upcoming Phase III trial for its COVID-19 booster candidate has been redesigned to compete against licensed mRNA-based vaccines.

  June 17, 2022

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Employer Resources

  Remote Workers More Productive in Short-Term Than Long-Term, Study Shows

  Researchers surveyed 60,000 Microsoft employees and found that remote workers are more productive than their in-office counterparts in the short-term, but less productive long term.

  June 17, 2022

   · 

  3 min read

   · 

  Franklin Carpenter
• 

  Drug Development

  Addex Ends Trials Evaluating Parkinson’s Treatment Due to Slow Recruitment

  Addex Therapeutics announced it is canceling its Phase IIb/III study evaluating its drug dipraglurant due to patient recruiting, staffing and pandemic-related issues.

  June 17, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Policy

  WTO Approves Patent Waivers to Increase Worldwide Access to COVID-19 Vaccines

  The World Trade Organization approved vaccine patent waivers to increase the availability of COVID-19 vaccines to lower-income countries.

  June 17, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Policy

  Acadia’s Alzheimer’s Drug Voted Down by FDA Advisory Committee

  An FDA advisory committee voted against Acadia Pharmaceutical’s supplemental New Drug Application of Nuplazid tablets for the treatment of Alzheimer’s-related psychosis.

  June 17, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Atreca Taps Genentech’s Stephen Gould to Serve as CSO

  Atreca announced that Stephen Gould, Ph.D., will be the company’s next chief scientific officer. Most recently, Gould was executive director, of Translational Oncology at Genentech.

  June 17, 2022

   · 

  1 min read

   · 

  Mark Terry
• 

  Drug Development

  Clinical Catch-Up: AbbVie and Genmab, Intra-Cellular, Sanofi and GSK

  Genmab and AbbVie announce positive data in large b-cell lymphoma, Intra-Cellular’s bipolar depression candidate hits the endpoint in Phase III and more.

  June 17, 2022

   · 

  6 min read

   · 

  Mark Terry
• 

  Policy

  FTC Unanimously Agrees to Keep Close Eye on PBMs, Higher Drug Costs

  The vote came just over one week after the FTC announced it would probe claims regarding the role the middlemen play in determining retail prices of prescription drugs.

  June 17, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  AstraZeneca Rumored to Have Set Sights on Mereo BioPharma Buyout

  AstraZeneca appears to have taken an interest in Mereo BioPharma and may be considering a buyout, according to speculations published by The Times UK.

  June 17, 2022

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug Development

  FDA Authorizes Pfizer-BioNTech, Moderna COVID Vaccines for Children 6 Months to 4 Years

  Friday morning, the FDA granted Emergency Use Authorization to both Moderna’s and Pfizer-BioNTech’s COVID-19 vaccines for use in children ages 6 months to 4 years old.

  June 17, 2022

   · 

  3 min read

   · 

  Alex Keown